1800 244 735

Helpline (02) 9874 9777

Coming soon: HD Therapeutics Conference 2012

An oasis of hope in the desert: the annual Huntington’s Disease Therapeutics Conference in Palm Springs, California, begins on 27th February. We’ll be bringing you live updates via Twitter and the web.

An exciting time

If 2011 is anything to go by, we predict that 2012 will be a big year for Huntington’s disease treatment research.

The new year has already brought exciting news of gene silencing success in primate trials and striking improvement in HD mice from injection of the ‘brain fat’ GM1.

Annual Therapeutics Conference

For the last 7 years the annual HD Therapeutics Conference in Palm Springs, California, has been a significant occasion for HD drug-hunters. It’s where the most exciting and cutting-edge treatment research is announced and discussed. It’s also a gathering of the world’s top HD researchers where ideas are shared and fruitful collaborations formed and nurtured.

The Conference begins very soon – Monday 27th February, to be exact. Your intrepid HDBuzz reporters Ed Wild and Jeff Carroll are going undercover at the Conference to bring you the latest news and buzz from the meeting.

The inside scoop from HDBuzz

Each day, we’ll be tweeting live updates from 9am to 6pm Pacific Time (that’s roughly 5pm to 2am in Europe). Follow @HDBuzzFeed on Twitter now, so you don’t miss anything.

If you prefer a daily digest, check HDBuzz.net or any of the HD sites that carry HDBuzz syndicated content. Each day’s news will be gathered together into a new article each evening, with our ever-popular ‘sunset conclusions’ to put things in context.

In the coming weeks, we’ll also bring you featured stories and interviews with some top scientists from the Conference.

Get in touch!

We want to hear from you, too, so send your questions, comments and queries to palmsprings@hdbuzz.net or tweet @HDBuzzFeed now or throughout the Conference.

So, get following, sign up for email updates and check the web frequently. Here’s looking forward to an inspiring Therapeutics Conference.

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest Research Articles

Updates from the EHDN Meeting 2021

Published date: 28 October, 2021

Last month, the Huntington’s disease (HD) research community, patients and other stakeholders met online at the European Huntington’s disease network (EHDN) conference. Despite the ongoing global pandemic, there is a tremendous amount of work underway in labs and clinics around the world as researchers continue to better understand HD and how we might best treat ... Read more

Real talk: Q&A with Roche about GENERATION-HD1

Published date: 28 September, 2021

At the end of day 1 of the European Huntington’s Disease Network (EHDN) conference, the HDBuzz team (minus one) sat down for a zoom chat with the team at Roche to have a frank, candid discussion about the recent halting of GENERATION-HD1, the Phase 3 clinical trial that was testing the ability of the antisense ... Read more

Another tool in the box: Creation of a molecular “dimmer switch” advances gene editing

Published date: 30 August, 2021

A team of scientists recently created an innovative genetic system where a drug taken by mouth could be used to control the action of a gene editor, like those used in CRISPR systems. This has useful applications for research studies in cells and animals, and perhaps most importantly, could lead to improvements in the safety ... Read more

Unpacking recent gene therapy press

Published date: 16 August, 2021

A recent announcement from Voyager Therapeutics outlined a shift in the company’s strategy towards an exciting new technology for gene therapy delivery. Unfortunately this also means that in the short term, they have dropped previous plans to test an HD gene therapy in people with HD. While this news is disappointing, the decision to embrace ... Read more

Does blood hold the key to testing treatments earlier in HD patients?

Published date: 4 August, 2021

Researchers at Johns Hopkins led by Wenzhen Duan have developed a non-invasive way to track progression of Huntington’s disease (HD) which could be used before patients even start showing symptoms. Using a type of brain scan called an MRI, the researchers have shown that in mouse models of HD they can accurately measure the amount ... Read more

A first for CRISPR gene editing could have wider applications for human disease

Published date: 21 July, 2021

A recent clinical trial successfully tested the safety of CRISPR gene editing to reduce the amount of a toxic protein in patients with Familial Transthyretic (TTR) Amyloidosis. Although this study is unrelated to Huntington’s disease, it’s a first for gene editing, and the results could have implications for HD and other brain disorders. CRISPR-Cas9 Clustered ... Read more